• Mission
  • Technology
  • Rheumatoid Arthritis
  • Contacts
  • Team
  • Newsroom
  • Publications

Publications

Advancing Precision Medicine Products in the Costliest Disease Areas

Latest publications
ABS0730 Treatment Sequencing and Line of Therapy for Biologics and JAK Inhibitors in Rheumatoid Arthritis Patients: Implications for Design and Uptake of New Drugs and Diagnostics
Annals of the Rheumatic Diseases
06/14/2025
POS0064 Development of a Blood-Based Cell-Free DNA Therapy Selection Test to Predict Biologic and Targeted Synthetic DMARDs Response in Rheumatoid Arthritis Patients (PRIMA-102)
Annals of the Rheumatic Diseases
06/14/2025
Development of a blood-based cell-free DNA therapy selection test to predict biologic and targeted synthetic DMARDs response in rheumatoid arthritis patients (PRIMA-102)
EULAR 2025
06/12/2025
Development of a blood-based cell-free DNA classifier test to predict response to b/ts DMARDs in RA patients (PRIMA-102)
CCR East, 2025
05/02/2025
A Novel Blood-based Assay that Predicts Clinical Response to TNFi or JAKi in Patients with Rheumatoid Arthritis
ACR 2024
11/15/2024
Development of a blood-based cell-free DNA classifier test to predict biologic and targeted synthetic DMARDs response in rheumatoid arthritis patients (PRIMA-102)
ACR 2024
11/15/2024
Extracting regulatory active chromatin footprint from cell-free DNA
Communications Biology - Nature
09/04/2024
A Novel Blood-Based Assay Differentiates Seropositive and Seronegative Rheumatoid Arthritis with High Sensitivity and Specificity from Healthy Individuals and Those with Other Inflammatory Diseases or Osteoarthritis.
EULAR 2024
06/13/2024
A Novel Blood-based Assay that Predicts Clinical Response to TNFi or JAKi in Patients with Rheumatoid Arthritis
CCR East, 2024
05/08/2024
PRIMA-102: Predicting Biologic and Targeted Synthetic DMARDs Response in Rheumatoid Arthritis Patients Using a Blood Based Cell-free DNA Classifier
CCR East, 2024
05/08/2024
Detection of non-small cell lung and bladder cancer signatures in peripheral blood using a novel active chromatin capture assay
AACR 2024
04/09/2024
A Novel Blood-Based Assay Differentiates Seropositive and Seronegative Rheumatoid Arthritis From Healthy Individuals and Those With Other Inflammatory Diseases or Osteoarthritis
ACR 2023
11/15/2023
Detection of Synovial Signatures in Peripheral Blood of Patients with Rheumatoid Arthritis via a Novel Blood-Based DNA Capture Assay
ACR 2023
11/12/2023
Review of Published Literature Reporting Economic Burden of Treatment Switching in Rheumatoid Arthritis
ACR 2023
11/12/2023
Aqtual Platform Technology White Paper
01/01/2024
© Copyright 2023. All Rights Reserved.
About
  • Mission
  • Technology
  • Rheumatoid Arthritis
Explore
  • Team
  • Newsroom
  • Publications
Contacts
  • LinkedIn
  • media@aqtual.com
  • 341-208-8569
Find us
31145 San Antonio St. Hayward, CA, 94544